SCHEMBL15519525

SCHEMBL15519525

CCN(CCc1noc(-c2ccc(F)c(F)c2)n1)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
PKM P14618 1/20 0.45
HPGD P15428 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NPY2R P49146 2/20 0.41
TP53 P04637 1/20 0.39
MAPK1 P28482 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA5 P30532 1/20 0.39
CHRNA4 P43681 1/20 0.39
GAA P10253 1/20 0.37
HCRTR1 O43613 2/20 0.37
HCRTR2 O43614 2/20 0.37
PPARG P37231 2/20 0.37
PPARA Q07869 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15520240 0.87 KDM4E (0.51) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL13833216 0.85 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL15519543 0.79 HCRTR1 (0.58) HCRTR1HCRTR2
SCHEMBL15519701 0.79 HCRTR1 (0.61) ALDH1A1CHRNB2CHRNA5CHRNA4HCRTR1
SCHEMBL15520600 0.78 HCRTR1 (0.60) HCRTR1HCRTR2
SCHEMBL25382664 0.76 CHRNB2 (0.46) NPC1RAB9AMAPTCHRNB2CHRNA5
SCHEMBL30567900 0.76 CHRNB2 (0.46) NPC1RAB9AMAPTCHRNB2CHRNA5
SCHEMBL15519527 0.74 S1PR1 (0.41) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL13833143 0.73 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25381836 0.73 KCNH2 (0.44) ALDH1A1SMN1; SMN2RAB9AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140081025-A1 HETEROAROMATIC RING DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-03-20 US disclosed
EP-2708537-A1 HETEROAROMATIC RING DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2014-03-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140081025-A1 HETEROAROMATIC RING DERIVATIVE HCRTR2, HCRTR1, HTT ALDH1A1 1060/4885SMN1; SMN2 2981/4885NPC1 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.